Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

coagulation factor VIIa (recombinant)-jncw (Sevenfact)

coagulation factor VIIa (recombinant)-jncw is an FDA-licensed reference biologic from Laboratoire Francais du Fractionnement et des Biotechnologies S.A..

351(a) biologicBLA 125641 Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2024

Reference product

Originator biologic
351(a)BLA 125641

Sevenfact coagulation factor VIIa (recombinant)-jncw

Laboratoire Francais du Fractionnement et des Biotechnologies S.A.

View full reference-product record
Approved
Marketing
Rx
Center
CBER
Patents
None listed

Molecular structure

RCSB Protein Data Bank

Experimental 3D structure for coagulation factor VIIa (recombinant)-jncw from the RCSB Protein Data Bank (PDB 1QFK).

3D molecular structure of coagulation factor VIIa (recombinant)-jncw (PDB entry 1QFK)

Interactive biological assembly from PDB entry 1QFK. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here, with no need to leave the page.

Exclusivity & patent cliffs

Protection horizon
  1. Reference approval

    Approval date of the reference coagulation factor VIIa (recombinant)-jncw product.

    2 yr 3 mo ago

coagulation factor VIIa (recombinant)-jncw: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for coagulation factor VIIa (recombinant)-jncw.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.